Eruptive Squamous Cell Carcinomas Following Treatment With Fludarabine
Eruptive squamous cell carcinoma
by NEXT STEPS IN DERM TEAM on
JDD authors Mihir Shah MD, Jenna Wald MD, and C. William Hanke MD MPH present a case of a patient with eruptive squamous cell carcinomas following treatment with Fludarabine to highlight not only the risk of cSCC in CLL patients and the increased risk for atypical cutaneous malignancies after treatment with systemic therapies such as fludarabine, but also to discuss treatment options for this …

Continue reading "Eruptive Squamous Cell Carcinomas Following Treatment With Fludarabine"

Cicatricial Alopecias: Practical Pearls for Challenging Diagnoses
cicatricial alopecias
by Nishad Sathe, MD on
At ODAC 2023, we had the opportunity to learn about cicatricial alopecias from renowned dermatologist and hair expert Dr. Amy McMichael, Professor of Dermatology at Wake Forest University School of Medicine. First, we considered a framework to check for cicatricial alopecias. This is particularly important because if we can identify cicatricial alopecia, we can make sure we are treating the rig …

Continue reading "Cicatricial Alopecias: Practical Pearls for Challenging Diagnoses"

Topical Ruxolitinib Therapeutic Cheat Sheet
Ruxolitinib
by Adam Rosenfeld, MD on
Ruxolitinib (OPZELURA) is a twice daily topical cream that is FDA approved for non-segmental vitiligo and mild to moderate atopic dermatitis1. JAK inhibitors are a class of drugs effective in treating a wide variety of inflammatory conditions. Initially only FDA approved for non-dermatologic conditions such as rheumatoid arthritis and ulcerative colitis, there is now strong evidence that JAK/STAT …

Continue reading "Topical Ruxolitinib Therapeutic Cheat Sheet"

Benefits and Risks of Medium & Deep Chemical Peels
chemical peels
by NEXT STEPS IN DERM TEAM on
Next Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium (PDE) interviewed Dr. Jennifer Rullan, a dermatologist in Chula Vista, Calif. Watch as Dr. Rullan outlines unexpected ingredients that dermatologists can use in medium depth and deep chemical peels to treat pigmentary disorders, and it may not be the disorders that you expect. Vitiligo? Idiopathic guttate hypomelanosis …

Continue reading "Benefits and Risks of Medium & Deep Chemical Peels"

Refractory Dissecting Cellulitis of the Scalp Treated With Risankizumab
Dissecting Cellulitis
by NEXT STEPS IN DERM TEAM on
Perifolliculitis capitis abscedens et suffodiens or dissecting cellulitis (DC) is a rare and chronic disease with a predilection for the occipital, vertex, and parietal scalp. DC is characterized by multinodular lesions with purulent drainage and sinus tract formation. It is classically seen in middle-aged males of African descent. The etiology of the disease is unknown; however, leading theories …

Continue reading "Refractory Dissecting Cellulitis of the Scalp Treated With Risankizumab"